CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease

Related Experiment Video

Updated: Aug 25, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Bill Newman1, Mark S Silverberg, Xiangjun Gu

  • 1Department of Medicine, University of Toronto, Toronto, Canada.

The American Journal of Gastroenterology
|March 30, 2004
PubMed

Insights

Genetic variants in CARD15 and HLA-DRB1 influence Crohn's disease (CD) susceptibility and disease site. Genotyping these variants can aid in diagnosing and predicting CD risk and ileal involvement.

Area of Science:

  • Genetics
  • Gastroenterology
  • Immunology

Background:

  • Crohn's disease (CD) is a chronic inflammatory bowel disease.
  • Genetic factors, including CARD15 and HLA-DRB1 gene variants, are known contributors to CD susceptibility.
  • Understanding the prevalence and impact of these variants in diverse populations is crucial for disease management.

Purpose of the Study:

  • To investigate the prevalence of CARD15 and HLA-DRB1 gene variants in a Canadian Crohn's disease cohort.
  • To determine the association of these genetic variants with CD susceptibility and clinical presentation, including disease location.
  • To evaluate the potential of combined genotyping for predicting disease characteristics.

Main Methods:

  • Genotyping of 507 unrelated CD patients for three major CARD15 variants (Arg702Trp, Gly908Arg, Leu1007fsinsC) and thirteen HLA-DRB1 alleles.
  • Comparison of variant prevalence between CD patients and controls.
  • Statistical analysis to assess associations between genotypes and clinical phenotypes.

Main Results:

  • At least one CARD15 variant was found in 32.5% of CD patients versus 20% of controls.
  • The Gly908Arg variant was more frequent in Jewish CD patients, while Arg702Trp was less frequent compared to non-Jewish patients.
  • HLA-DRB1*0103 was associated with increased CD risk (6.7-fold), later diagnosis, and colonic disease, while CARD15 variants were linked to ileal involvement (OR=1.8).
  • Combined CARD15 and HLA-DRB1 genotyping predicted ileal disease with significant accuracy.

Conclusions:

  • CARD15 and HLA-DRB1 alleles significantly influence Crohn's disease susceptibility and the site of inflammation.
  • Genotyping these genetic variants offers a promising tool for enhanced diagnosis and risk stratification in CD patients.
  • This approach can help personalize patient management strategies based on genetic predisposition and predicted disease course.
Abstract

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...